COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome

Introduction. Acute exacerbation of interstitial lung disease (ILD) and COVID-19 pneumonia show many similarities, but also COVID-19 sequelae, mainly when fibrotic features are present, can be difficult to distinguish from chronic ILD observed in connective tissue diseases. Case Report. In 2018, a 5...

Full description

Saved in:
Bibliographic Details
Main Authors: Alessia Laneri, Stefania Cerri, Giovanni Della Casa, Antonio Moretti, Andreina Manfredi, Marco Sebastiani, Enrico Clini, Carlo Salvarani
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2023/9915553
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558453689679872
author Alessia Laneri
Stefania Cerri
Giovanni Della Casa
Antonio Moretti
Andreina Manfredi
Marco Sebastiani
Enrico Clini
Carlo Salvarani
author_facet Alessia Laneri
Stefania Cerri
Giovanni Della Casa
Antonio Moretti
Andreina Manfredi
Marco Sebastiani
Enrico Clini
Carlo Salvarani
author_sort Alessia Laneri
collection DOAJ
description Introduction. Acute exacerbation of interstitial lung disease (ILD) and COVID-19 pneumonia show many similarities, but also COVID-19 sequelae, mainly when fibrotic features are present, can be difficult to distinguish from chronic ILD observed in connective tissue diseases. Case Report. In 2018, a 52-year-old woman, was diagnosed with primary Sjogren’s syndrome (pSS). The patient did not show respiratory symptoms, and a chest X-ray was normal. During March 2020, the patient was hospitalized for acute respiratory failure related to COVID-19 pneumonia. Three months later, follow-up chest high-resolution computed tomography (HRCT) showed ground glass opacity (GGO) and interlobular interstitial thickening. Pulmonary function tests (PFTs) showed slight restrictive deficit and mild reduction in diffusion lung of carbon monoxide (DLCO). The patient complained of asthenia and exertional dyspnoea. A multidisciplinary discussion including rheumatologist, pulmonologist, and thoracic radiologist did not allow a definitive differential diagnosis between COVID-19 persisting abnormalities and a previous or new-onset pSS-ILD. A “wait and see” approach was decided, monitoring clinical conditions, PFTs, and chest HRCT over time. Only 2 years after the hospitalization, improvement of clinical symptoms was reported; PFT also improved, and HRCT showed almost complete resolution of GGO and interlobular interstitial thickening, confirming the diagnostic hypothesis of long-COVID lung manifestations. Discussion. In the above-reported case report, 3 differential diagnoses were possible: a COVID-19-related ILD, a preexisting pSS-ILD, or a new-onset pSS-ILD triggered by COVID-19. Regardless of the diagnosis, the persistence of clinical and PFT alterations, suggested a chronic disease but, surprisingly, clinical and radiologic manifestations disappeared 2 years later.
format Article
id doaj-art-6dee9ba7cae944f0b9fc801936ce1ca8
institution Kabale University
issn 1687-9635
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-6dee9ba7cae944f0b9fc801936ce1ca82025-02-03T01:32:19ZengWileyCase Reports in Medicine1687-96352023-01-01202310.1155/2023/9915553COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s SyndromeAlessia Laneri0Stefania Cerri1Giovanni Della Casa2Antonio Moretti3Andreina Manfredi4Marco Sebastiani5Enrico Clini6Carlo Salvarani7Rheumatology UnitRespiratory Diseases Unit and Center for Rare Lung DiseasesRadiology UnitRespiratory Diseases Unit and Center for Rare Lung DiseasesRheumatology UnitRheumatology UnitRespiratory Diseases Unit and Center for Rare Lung DiseasesRheumatology UnitIntroduction. Acute exacerbation of interstitial lung disease (ILD) and COVID-19 pneumonia show many similarities, but also COVID-19 sequelae, mainly when fibrotic features are present, can be difficult to distinguish from chronic ILD observed in connective tissue diseases. Case Report. In 2018, a 52-year-old woman, was diagnosed with primary Sjogren’s syndrome (pSS). The patient did not show respiratory symptoms, and a chest X-ray was normal. During March 2020, the patient was hospitalized for acute respiratory failure related to COVID-19 pneumonia. Three months later, follow-up chest high-resolution computed tomography (HRCT) showed ground glass opacity (GGO) and interlobular interstitial thickening. Pulmonary function tests (PFTs) showed slight restrictive deficit and mild reduction in diffusion lung of carbon monoxide (DLCO). The patient complained of asthenia and exertional dyspnoea. A multidisciplinary discussion including rheumatologist, pulmonologist, and thoracic radiologist did not allow a definitive differential diagnosis between COVID-19 persisting abnormalities and a previous or new-onset pSS-ILD. A “wait and see” approach was decided, monitoring clinical conditions, PFTs, and chest HRCT over time. Only 2 years after the hospitalization, improvement of clinical symptoms was reported; PFT also improved, and HRCT showed almost complete resolution of GGO and interlobular interstitial thickening, confirming the diagnostic hypothesis of long-COVID lung manifestations. Discussion. In the above-reported case report, 3 differential diagnoses were possible: a COVID-19-related ILD, a preexisting pSS-ILD, or a new-onset pSS-ILD triggered by COVID-19. Regardless of the diagnosis, the persistence of clinical and PFT alterations, suggested a chronic disease but, surprisingly, clinical and radiologic manifestations disappeared 2 years later.http://dx.doi.org/10.1155/2023/9915553
spellingShingle Alessia Laneri
Stefania Cerri
Giovanni Della Casa
Antonio Moretti
Andreina Manfredi
Marco Sebastiani
Enrico Clini
Carlo Salvarani
COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
Case Reports in Medicine
title COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
title_full COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
title_fullStr COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
title_full_unstemmed COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
title_short COVID-19, A New Possible Mimicker of Interstitial Lung Disease Related to Primary Sjögren’s Syndrome
title_sort covid 19 a new possible mimicker of interstitial lung disease related to primary sjogren s syndrome
url http://dx.doi.org/10.1155/2023/9915553
work_keys_str_mv AT alessialaneri covid19anewpossiblemimickerofinterstitiallungdiseaserelatedtoprimarysjogrenssyndrome
AT stefaniacerri covid19anewpossiblemimickerofinterstitiallungdiseaserelatedtoprimarysjogrenssyndrome
AT giovannidellacasa covid19anewpossiblemimickerofinterstitiallungdiseaserelatedtoprimarysjogrenssyndrome
AT antoniomoretti covid19anewpossiblemimickerofinterstitiallungdiseaserelatedtoprimarysjogrenssyndrome
AT andreinamanfredi covid19anewpossiblemimickerofinterstitiallungdiseaserelatedtoprimarysjogrenssyndrome
AT marcosebastiani covid19anewpossiblemimickerofinterstitiallungdiseaserelatedtoprimarysjogrenssyndrome
AT enricoclini covid19anewpossiblemimickerofinterstitiallungdiseaserelatedtoprimarysjogrenssyndrome
AT carlosalvarani covid19anewpossiblemimickerofinterstitiallungdiseaserelatedtoprimarysjogrenssyndrome